Literature DB >> 16419135

A microdeletion in Xp11.3 accounts for co-segregation of retinitis pigmentosa and mental retardation in a large kindred.

Lilei Zhang1, Tao Wang, Alan F Wright, Mohnish Suri, Charles E Schwartz, Roger E Stevenson, David Valle.   

Abstract

In a previous report, Aldred et al. [1994] described a 5-generation family in which severe retinitis pigmentosa (RP) co-segregates with mild-moderate mental retardation as an X-linked recessive phenotype mapping to the broad interval between Xp21-q21. We re-examined this family, initially analyzing RP2, a gene in the disease interval that was identified as a cause of RP after the initial report of this family. We found that the male propositus lacked the 5' three exons of RP2 and that RP2 marks the centromeric boundary of a 1.27 Mb deletion that includes two other annotated genes (SLC9A7, CHST7), one predicted transcript encoding a zinc finger protein (FLJ20344) and two highly conserved miRNAs (mir221, mir222). We conclude that this family is segregating a contiguous gene deletion and that the absence of a functional RP2 accounts, at least in part, for the retinal degeneration while deletion of one or more of the other genes is likely responsible for the mental retardation phenotype. Copyright (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16419135     DOI: 10.1002/ajmg.a.31080

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  10 in total

Review 1.  MicroRNAs in brain function and disease.

Authors:  Andreas Walter Kuss; Wei Chen
Journal:  Curr Neurol Neurosci Rep       Date:  2008-05       Impact factor: 5.081

Review 2.  Small regulatory RNAs in neurodevelopmental disorders.

Authors:  Shuang Chang; Shengmei Wen; Dahua Chen; Peng Jin
Journal:  Hum Mol Genet       Date:  2009-04-15       Impact factor: 6.150

3.  Functional characterization of Na+/H+ exchangers of intracellular compartments using proton-killing selection to express them at the plasma membrane.

Authors:  Nina Milosavljevic; Mallorie Poët; Michael Monet; Eléonore Birgy-Barelli; Isabelle Léna; Laurent Counillon
Journal:  J Vis Exp       Date:  2015-03-30       Impact factor: 1.355

4.  MicroRNA-215 Regulates Fibroblast Function: Insights from a Human Fibrotic Disease.

Authors:  Wanwen Lan; Silin Chen; Louis Tong
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

5.  MicroRNAs: a light into the "black box" of neuropediatric diseases?

Authors:  Ahmed Omran; Dalia Elimam; Sherien Shalaby; Jing Peng; Fei Yin
Journal:  Neuromolecular Med       Date:  2012-07-19       Impact factor: 3.843

6.  A High-Throughput Drug Screening Strategy for Detecting Rhodopsin P23H Mutant Rescue and Degradation.

Authors:  Yuanyuan Chen; Hong Tang; William Seibel; Ruben Papoian; Xiaoyu Li; Nevin A Lambert; Krzysztof Palczewski
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-04       Impact factor: 4.799

7.  Downregulation of miR-221/222 enhances sensitivity of breast cancer cells to tamoxifen through upregulation of TIMP3.

Authors:  R Gan; Y Yang; X Yang; L Zhao; J Lu; Q H Meng
Journal:  Cancer Gene Ther       Date:  2014-06-13       Impact factor: 5.987

8.  Intellectual disability associated with retinal dystrophy in the Xp11.3 deletion syndrome: ZNF674 on trial. Guilty or innocent?

Authors:  Nathalie Delphin; Sylvain Hanein; Lucas Fares Taie; Xavier Zanlonghi; Dominique Bonneau; Jean-Paul Moisan; Christine Boyle; Patrick Nitschke; Solenn Pruvost; Jean-Paul Bonnefont; Arnold Munnich; Olivier Roche; Josseline Kaplan; Jean-Michel Rozet
Journal:  Eur J Hum Genet       Date:  2011-11-30       Impact factor: 4.246

Review 9.  Noncoding RNAs in mental retardation.

Authors:  K E Szulwach; P Jin; R S Alisch
Journal:  Clin Genet       Date:  2009-01-20       Impact factor: 4.438

10.  Dynamic monitoring of circulating microRNAs as a predictive biomarker for the diagnosis and recurrence of papillary thyroid carcinoma.

Authors:  Yanqing Zhang; Desheng Xu; Jiaqi Pan; Zhengkai Yang; Meijun Chen; Jun Han; Sijia Zhang; Lulu Sun; Hong Qiao
Journal:  Oncol Lett       Date:  2017-04-11       Impact factor: 2.967

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.